Millions suffering from myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), a debilitating condition often overlooked due to the lack of diagnostic tools, may be closer to personalized care, according to new research that shows how the disease disrupts interactions between the microbiome, immune system, and metabolism.
Previously undetectable biomarkers in gut microbiome may predict ‘invisible’ chronic fatigue syndrome, long COVID
